These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17022778)

  • 41. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuropsychological measures in normal individuals that predict subsequent cognitive decline.
    Blacker D; Lee H; Muzikansky A; Martin EC; Tanzi R; McArdle JJ; Moss M; Albert M
    Arch Neurol; 2007 Jun; 64(6):862-71. PubMed ID: 17562935
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele.
    O'Hara R; Sommer B; Way N; Kraemer HC; Taylor J; Murphy G
    J Psychiatr Res; 2008 Feb; 42(3):199-204. PubMed ID: 17250852
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The APOE polymorphism and 1-year outcome in ischemic stroke: genotype-gender interaction.
    Gromadzka G; Baranska-Gieruszczak M; Sarzynska-Dlugosz I; Ciesielska A; Czlonkowska A
    Acta Neurol Scand; 2007 Dec; 116(6):392-8. PubMed ID: 17986098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Homocysteine and cognitive performance: modification by the ApoE genotype.
    Elias MF; Robbins MA; Budge MM; Elias PK; Dore GA; Brennan SL; Johnston C; Nagy Z
    Neurosci Lett; 2008 Jan; 430(1):64-9. PubMed ID: 18023533
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Systemic markers of inflammation and cognitive decline in old age.
    Schram MT; Euser SM; de Craen AJ; Witteman JC; Frölich M; Hofman A; Jolles J; Breteler MM; Westendorp RG
    J Am Geriatr Soc; 2007 May; 55(5):708-16. PubMed ID: 17493190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The contribution of apolipoprotein E alleles on cognitive performance and dynamic neural activity over six decades.
    Alexander DM; Williams LM; Gatt JM; Dobson-Stone C; Kuan SA; Todd EG; Schofield PR; Cooper NJ; Gordon E
    Biol Psychol; 2007 Jul; 75(3):229-38. PubMed ID: 17433528
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regional brain atrophy in cognitively intact adults with a single APOE epsilon4 allele.
    Wishart HA; Saykin AJ; McAllister TW; Rabin LA; McDonald BC; Flashman LA; Roth RM; Mamourian AC; Tsongalis GJ; Rhodes CH
    Neurology; 2006 Oct; 67(7):1221-4. PubMed ID: 17030756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polymorphisms at the beta2-adrenergic receptor gene influence Alzheimer's disease susceptibility.
    Yu JT; Tan L; Ou JR; Zhu JX; Liu K; Song JH; Sun YP
    Brain Res; 2008 May; 1210():216-22. PubMed ID: 18423577
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Apolipoprotein E genotype does not associate with disease severity measured by Multiple Sclerosis Severity Score.
    Guerrero AL; Laherrán E; Gutiérrez F; Martín-Polo J; Iglesias F; Alcázar C; Peralta J; Rostami P
    Acta Neurol Scand; 2008 Jan; 117(1):21-5. PubMed ID: 17883422
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of ApoE genotype and mild cognitive impairment on implicit learning.
    Negash S; Petersen LE; Geda YE; Knopman DS; Boeve BF; Smith GE; Ivnik RJ; Howard DV; Howard JH; Petersen RC
    Neurobiol Aging; 2007 Jun; 28(6):885-93. PubMed ID: 16701920
    [TBL] [Abstract][Full Text] [Related]  

  • 52. ApoE polymorphism and acute stroke: a study with diffusion- and perfusion-weighted MRI and MR angiography.
    Liu Y; Nuutinen J; Laakso MP; Karonen JO; Soimakallio S; Aronen HJ; Vanninen RL
    Acta Neurol Scand; 2006 Nov; 114(5):323-8. PubMed ID: 17022780
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Increase in cerebrospinal fluid F2-isoprostanes is related to cognitive decline in APOE ε4 carriers.
    Duits FH; Kester MI; Scheffer PG; Blankenstein MA; Scheltens P; Teunissen CE; van der Flier WM
    J Alzheimers Dis; 2013; 36(3):563-70. PubMed ID: 23629585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Increased mental slowing associated with the APOE epsilon4 allele after trihexyphenidyl oral anticholinergic challenge in healthy elderly.
    Pomara N; Belzer K; Hernando R; De La Pena C; Sidtis JJ
    Am J Geriatr Psychiatry; 2008 Feb; 16(2):116-24. PubMed ID: 18239197
    [TBL] [Abstract][Full Text] [Related]  

  • 55. APOE epsilon4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Mazurek AA; Shi J
    Neurology; 2008 Oct; 71(15):1203; author reply 1203. PubMed ID: 18838671
    [No Abstract]   [Full Text] [Related]  

  • 56. Increased frequency of positive family history of dementia in sporadic CJD.
    Krasnianski A; von Ahsen N; Heinemann U; Meissner B; Schulz-Schaeffer WJ; Kretzschmar HA; Armstrong VW; Zerr I
    Neurobiol Aging; 2009 Apr; 30(4):615-21. PubMed ID: 17822808
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apolipoprotein E epsilon4 allele is associated with Parkinson disease risk in a Mexican Mestizo population.
    López M; Guerrero J; Yescas P; Boll MC; Familiar I; Ochoa A; Rasmussen A; Alonso ME
    Mov Disord; 2007 Feb; 22(3):417-20. PubMed ID: 17230455
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of apolipoprotein e in the pathological events following subarachnoid hemorrhage: a review.
    Guo ZD; Sun XC; Zhang JH
    Acta Neurochir Suppl; 2011; 110(Pt 2):5-7. PubMed ID: 21125436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The APOE epsilon4 allele increases the risk of impaired spatial working memory in obstructive sleep apnea.
    Cosentino FI; Bosco P; Drago V; Prestianni G; Lanuzza B; Iero I; Tripodi M; Spada RS; Toscano G; Caraci F; Ferri R
    Sleep Med; 2008 Dec; 9(8):831-9. PubMed ID: 18083630
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Longitudinal change in cognitive performance among individuals with mild cognitive impairment.
    Albert M; Blacker D; Moss MB; Tanzi R; McArdle JJ
    Neuropsychology; 2007 Mar; 21(2):158-69. PubMed ID: 17402816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.